Phacilitate Leaders Forum

17th - 18th SEPTEMBER 2019

ROYAL LANCASTER LONDON

Agenda

Agenda

Agenda

This year, the agenda has been designed to address the 3 core challenges presented by the European advanced therapies market: investment and innovation, manufacturing and commercialisation, and patient access and healthcare. Bringing cell, gene and cellular IO into each of the tracks will facilitate the cross-pollination of these 3 modalities. 

In short, we aim to provide answers to the issues of the entire ecosystem of ATMPs, all the way from the conception of your cell and gene therapy, to introducing it to market and patient access. 

Loading
  1. Registration for Phacilitate Leaders Europe opens
  1. Opening Plenary: On the road to success - exploring the opportunities of commercialising ATMPs in Europe

  2. Opening Plenary: On the road to success - exploring the opportunities of commercialising ATMPs in Europe

  3. Opening Plenary: On the road to success - exploring the opportunities of commercialising ATMPs in Europe

  4. Opening Plenary: On the road to success - exploring the opportunities of commercialising ATMPs in Europe

  5. Opening Plenary: On the road to success - exploring the opportunities of commercialising ATMPs in Europe

  1. Morning Networking Coffee Break
  1. Investment & Innovation

    Enabling the translation of European innovation through global investment

  2. Investment & Innovation

    Enabling the translation of European innovation through global investment

  3. Investment & Innovation

    Enabling the translation of European innovation through global investment

  4. Investment & Innovation

    Enabling the translation of European innovation through global investment

  1. Manufacturing & Commercialisation

    Overcoming regulatory barriers in manufacturing ATMPs - updates and pain points

  2. Manufacturing & Commercialisation

    Overcoming regulatory barriers in manufacturing ATMPs - updates and pain points

  3. Manufacturing & Commercialisation

    Overcoming regulatory barriers in manufacturing ATMPs - updates and pain points

  4. Manufacturing & Commercialisation

    Overcoming regulatory barriers in manufacturing ATMPs - updates and pain points

  5. Manufacturing & Commercialisation

    Overcoming regulatory barriers in manufacturing ATMPs - updates and pain points

  1. Patient Access & Healthcare

    Regulatory harmonisation in a fragmented European society; staying ahead of the curve

  2. Patient Access & Healthcare

    Regulatory harmonisation in a fragmented European society; staying ahead of the curve

  3. Patient Access & Healthcare

    Regulatory harmonisation in a fragmented European society; staying ahead of the curve

  4. Patient Access & Healthcare

    Regulatory harmonisation in a fragmented European society; staying ahead of the curve

  5. Patient Access & Healthcare

    Regulatory harmonisation in a fragmented European society; staying ahead of the curve

  1. Lunch
  1. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  2. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  3. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  4. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  5. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  6. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  7. Investment & Innovation

    Company spotlight: uncovering tomorrow's innovation

  1. Manufacturing & Commercialisation

    Planning an in-house facility - a deep dive into practical requirements and examples of lessons learned

  2. Manufacturing & Commercialisation

    Planning an in-house facility in Europe - a deep dive into practical requirements and examples of lessons learned

  3. Manufacturing & Commercialisation

    Planning an in-house facility in Europe - a deep dive into practical requirements and examples of lessons learned

  4. Manufacturing & Commercialisation

    Planning an in-house facility in Europe - a deep dive into practical requirements and examples of lessons learned

  5. Manufacturing & Commercialisation

    Planning an in-house facility in Europe - a deep dive into practical requirements and examples of lessons learned

  6. Manufacturing & Commercialisation

    Planning an in-house facility in Europe - a deep dive into practical requirements and examples of lessons learned

  1. Patient Access & Healthcare

    Surpassing European market access hurdles; future pricing & reimbursement strategies to enable patient access

  2. Patient Access & Healthcare

    Surpassing European market access hurdles; future pricing & reimbursement strategies to enable patient access

  3. Patient Access & Healthcare

    Surpassing European market access hurdles; future pricing & reimbursement strategies to enable patient access

  4. Patient Access & Healthcare

    Surpassing European market access hurdles; future pricing & reimbursement strategies to enable patient access

  5. Patient Access & Healthcare

    Surpassing European market access hurdles; future pricing & reimbursement strategies to enable patient access

  1. Afternoon Networking Coffee Break
  1. Manufacturing & Commercialisation

    The future of manufacturing ATMPs through the lens of vector production capacity - novel approaches and solutions

  2. Manufacturing & Commercialisation

    The future of manufacturing ATMPs through the lens of viral vector production capacity - novel approaches and solutions

  3. Manufacturing & Commercialisation

    Approaches to introducing non-viral vector technology into existing manufacturing processes for future sustainability of ATMPs production in Europe

  4. Manufacturing & Commercialisation

    The future of manufacturing ATMPs through the lens of viral vector production capacity - novel approaches and solutions

  5. Manufacturing & Commercialisation

    Approaches to introducing non-viral vector technology into existing manufacturing processes for future sustainability of ATMPs production in Europe

  1. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  2. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  3. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  4. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  5. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  6. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  7. Patient Access & Healthcare

    ADVANCED THERAPIES NETWORK SYMPOSIUM IN PARTNERSHIP WITH PHACILITATE

  1. Networking Drinks
  1. Registration
  1. Morning Networking Coffee Break
  1. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  2. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  3. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  4. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  5. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  6. Investment & Innovation

    The European cellular IO clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  1. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  2. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  3. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  4. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  5. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  6. Manufacturing & Commercialisation

    Speeding up Product Commercialization through Robust Process Development

  1. Patient Access & Healthcare

    Easing the standardisation burden in European healthcare; a roadmap to commercial success

  2. Patient Access & Healthcare

    Easing the standardisation burden in European healthcare; a roadmap to commercial success

  3. Patient Access & Healthcare

    Easing the standardisation burden in European healthcare; a roadmap to commercial success

  4. Patient Access & Healthcare

    Easing the standardisation burden in European healthcare; a roadmap to commercial success

  5. Patient Access & Healthcare

    Easing the standardisation burden in European healthcare; a roadmap to commercial success

  1. Lunch
  1. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  2. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  3. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  4. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  5. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  6. Investment & Innovation

    The European gene therapy clinical revolution; understanding opportunities and challenges to reinforce success on the continent

  1. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  2. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  3. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  4. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  5. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  6. Manufacturing & Commercialisation

    A practical look at quality control and analytics across all stages of development

  1. Patient Access & Healthcare

    Designing a robust European logistics strategy across member states; lessons learnt

  2. Patient Access & Healthcare

    Designing a robust European logistics strategy across member states; lessons learnt

  3. Patient Access & Healthcare

    Designing a robust European logistics strategy across member states; lessons learnt

  4. Patient Access & Healthcare

    Designing a robust European logistics strategy across member states; lessons learnt

  5. Patient Access & Healthcare

    Designing a robust European logistics strategy across member states; lessons learnt

  1. Afternoon Networking Coffee Break
  1. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  2. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  3. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  4. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  5. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  6. Manufacturing & Commercialisation

    Automation - considering the right size and fit for individual products and processes

  1. Patient Access & Healthcare

    Setting up healthcare infrastructure across the EU; future proofing patient access for ATMPs

  2. Patient Access & Healthcare

    Setting up healthcare infrastructure across the EU; future proofing patient access for ATMPs

  3. Patient Access & Healthcare

    Setting up healthcare infrastructure across the EU; future proofing patient access for ATMPs

  4. Patient Access & Healthcare

    Setting up healthcare infrastructure across the EU; future proofing patient access for ATMPs

  5. Patient Access & Healthcare

    Setting up healthcare infrastructure across the EU; future proofing patient access for ATMPs

  1. End of Conference

Join the advanced therapies community 

Phacilitate Leaders Europe - LinkedIn Phacilitate Leaders Europe - instagram Phacilitate Leaders Europe youtube Phacilitate Leaders Europe - Twitter
Testimonials
  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
    Celyad
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd